References
Ben Salem C, Fathallah N, Hmouda H, et al. Drug-induced hypoglycaemia: an update. Drug Safety 2011; 34(1): 21–45
British Medical Association and the Royal Pharmaceutical Society of Great Britain. British national formulary. No. 62. London: BMJ Publishing Group Ltd and RPS Publishing, 2011 Sep
Guettier JM, Gorden P. Hypoglycemia. Endocrinol Metab Clin North Am 2006 Dec; 35(4): 753–66
Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005 May; 28(5): 1245–9
Cryer PE. Preventing hypoglycaemia: what is the appropriate glucose alert value? Diabetologia 2009 Jan; 52(1): 35–7
Cryer PE. Symptoms of hypoglycaemia, thresholds for their occurrence, and hypoglycaemia unawareness. Endocrinol Metab Clin North Am 1999 Sep; 28(3): 495–500
Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 2002 Jul; 45(7): 937–48
UK Prospective Diabetes Study Group 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group. Diabetes 1995 Nov; 44(11): 1249–58
Boyle PJ, Zrebiec J. Management of diabetes-related hypoglycaemia. South Med J 2007 Feb; 100(2): 183–94
Gabriely I, Shamoon H. Hypoglycemia in diabetes: common, often unrecognized. Cleve Clin J Med 2004 Apr; 71(4): 335–42
Rights and permissions
About this article
Cite this article
Awareness is the key to preventing and/or minimizing drug-induced hypoglycaemia. Drugs Ther Perspect 28, 19–23 (2012). https://doi.org/10.2165/11207960-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11207960-000000000-00000